- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles1 new
- Related Articles1 new
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
RDY Market Currents
more »
-
May 11 Dr. Reddy's Laboratories (RDY): FQ4 EPS of $0.40 in-line. Revenue of $522M (+32% Y/Y) beats by $126M. (PR)
Comment![Earnings, Healthcare]
RDY in Focus
more »
RDY Related Articles
more »
RDY News
more »
-
at MarketWatch.com (May 18, 2012)
-
at MarketWatch.com (Jul 15, 2011)
-
at MarketWatch.com (Mar 10, 2011)
-
at CNBC.com (Feb 17, 2011)
-
at CNBC.com (Feb 1, 2011)
RDY Press Releases and Filings
more »
-
Business Wire (Apr 19, 2012)
-
Business Wire (Jan 16, 2012)
RDY Latest Transcript
more »
-
Fri, May 11
RDY Cramer
more »
-
Wed, Jul 30, 2008
-
Thu, May 4, 2006
RDY Instablog posts
more »
RDY vs. ETF Alternatives
Company Description
Currently, there's no company description for RDY.
